Qube Research & Technologies (QRT)’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-200
Closed -$27.6K 3941
2025
Q4
$27.6K Hold
200
﹤0.01% 3351
2025
Q3
$25.6K Sell
200
-200
-50% -$24.4K ﹤0.01% 3266
2025
Q2
$48.4K Sell
400
-1,800
-82% -$203K ﹤0.01% 3155
2025
Q1
$245K Sell
2,200
-1,000
-31% -$106K ﹤0.01% 2802
2024
Q4
$311K Buy
3,200
+1,500
+88% +$160K ﹤0.01% 2699
2024
Q3
$196K Buy
+1,700
New +$193K ﹤0.01% 2590

Other funds holding NVS

Qube Research & Technologies (QRT)'s NVS Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its Novartis (NVS) stake by 46% in Q1 2026, buying an estimated $8.36M and bringing the position to 173,137 shares worth $26.4M. The position accounts for 0.03% of the portfolio, ranked #720.

Qube Research & Technologies (QRT) first reported a position in NVS in Q4 2019 and has held it in 21 quarters since. The position peaked at $70.6M in Q1 2024. 1,591 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Qube Research & Technologies (QRT) held 173,137 shares of Novartis worth $26.4M as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 54,510 Novartis shares in Q1 2026, an estimated $8.36M.
  • Novartis made up 0.03% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #720 holding.
  • Qube Research & Technologies (QRT) first reported a position in Novartis in Q4 2019 and has held it in 21 quarters since.
  • Qube Research & Technologies (QRT)'s Novartis position peaked at $70.6M in Q1 2024.
  • 1,591 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.